MedTrace Logo

Study to Evaluate the Response to Supplementation With Postbiotics in Patients With Macular Degeneration.

NCT05056025 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2021-09-24

No results posted yet for this study

Summary

A pilot study to establish the efficacy and safety of supplementation with postbiotics in patients with macular degeneration.

Conditions

  • AMD
  • Soft Drusen
  • Reticular Pseudodrusen
  • Drusen Stage Macular Degeneration
  • Drusen (Degenerative) of Macula, Bilateral

Interventions

DIETARY_SUPPLEMENT

Postbotics and Vitamins

2 capsule 3 times a day, before meals

DIETARY_SUPPLEMENT

Vitamins

2 capsule 3 times a day, before meals

Sponsors & Collaborators

  • Igen BioLab SLU

    collaborator INDUSTRY

  • Institut de la Macula y la Retina

    lead OTHER

Principal Investigators

  • Jordi Mones, MD, PhD · Institut de la Macula

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-02
Primary Completion
2023-01-31
Completion
2024-01-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05056025 on ClinicalTrials.gov